首页> 外文期刊>Nature >Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
【24h】

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

机译:在SARS-COV-2穗上对多个表位的有效中和抗体

获取原文
获取原文并翻译 | 示例
           

摘要

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic continues, with devasting consequences for human lives and the global economy(1,2). The discovery and development of virus-neutralizing monoclonal antibodies could be one approach to treat or prevent infection by this coronavirus. Here we report the isolation of sixty-one SARS-CoV-2-neutralizing monoclonal antibodies from five patients infected with SARS-CoV-2 and admitted to hospital with severe coronavirus disease 2019 (COVID-19). Among these are nineteen antibodies that potently neutralized authentic SARS-CoV-2 in vitro, nine of which exhibited very high potency, with 50% virus-inhibitory concentrations of 0.7 to 9 ng ml(-1). Epitope mapping showed that this collection of nineteen antibodies was about equally divided between those directed against the receptor-binding domain (RBD) and those directed against the N-terminal domain (NTD), indicating that both of these regions at the top of the viral spike are immunogenic. In addition, two other powerful neutralizing antibodies recognized quaternary epitopes that overlap with the domains at the top of the spike. Cryo-electron microscopy reconstructions of one antibody that targets the RBD, a second that targets the NTD, and a third that bridges two separate RBDs showed that the antibodies recognize the closed, 'all RBD-down' conformation of the spike. Several of these monoclonal antibodies are promising candidates for clinical development as potential therapeutic and/or prophylactic agents against SARS-CoV-2.
机译:严重的急性呼吸综合征冠状病毒-2(SARS-COV-2)大流行持续,对人类生活和全球经济的破坏后果(1,2)。病毒中和单克隆抗体的发现和开发可以是治疗或预防该冠状病毒感染的一种方法。在这里,我们报告了来自感染SARS-COV-2的五名患者的六十六个SARS-COV-2中和单克隆抗体的分离,并参加​​了2019年严重冠状病毒疾病的医院(Covid-19)。其中包括十九六个抗体,其在体外具有纯粹的典型的SARS-COV-2,其中九个具有非常高的效力,病毒抑制浓度为0.7至9ng mL(-1)。表位映射表明,该收集在含有对受体结合结构域(RBD)的那些之间的那些近似分裂,指向含有N-末端结构域(NTD)的那些,表明病毒顶部的这些区域都是两种区域穗是免疫原性的。此外,另外两种强大的中和抗体认可的季齿性表位与尖峰顶部的域重叠。靶向RBD的一抗的冷冻电子显微镜重建,靶向NTD的一秒钟,以及桥接两个单独的RBD的第三个抗体表明抗体识别封闭,“所有RBD-unply”的峰值构象。这些单克隆抗体中的几种是临床开发的候选者,作为针对SARS-COV-2的潜在治疗和/或预防剂。

著录项

  • 来源
    《Nature》 |2020年第7821期|450-456|共7页
  • 作者单位

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Zuckerman Mind Brain Behav Inst New York NY 10027 USA;

    Harvard Med Sch Dana Farber Canc Inst Boston MA 02115 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Univ Hong Kong Li Ka Shing Fac Med Dept Microbiol State Key Lab Emerging Infect Dis Carol Yu Ctr In Hong Kong Peoples R China|Univ Hong Kong Health InnoHK Ctr Virol Vaccinol & Therapeut Hong Kong Peoples R China;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Dept Microbiol & Immunol Flow Cytometry Core New York NY USA;

    Columbia Univ Vagelos Coll Phys & Surg Human Immune Monitoring Core New York NY USA;

    NIH Vaccine Res Ctr Bldg 10 Bethesda MD 20892 USA;

    NIH Vaccine Res Ctr Bldg 10 Bethesda MD 20892 USA;

    Univ Hong Kong Li Ka Shing Fac Med Dept Microbiol State Key Lab Emerging Infect Dis Carol Yu Ctr In Hong Kong Peoples R China|Univ Hong Kong Health InnoHK Ctr Virol Vaccinol & Therapeut Hong Kong Peoples R China|Univ Hong Kong Li Ka Shing Fac Med AIDS Inst Hong Kong Peoples R China;

    Univ Hong Kong Li Ka Shing Fac Med Dept Microbiol State Key Lab Emerging Infect Dis Carol Yu Ctr In Hong Kong Peoples R China;

    Columbia Univ Dept Biochem New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Dept Internal Med Div Infect Dis New York NY USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA|Columbia Univ Zuckerman Mind Brain Behav Inst New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA|Columbia Univ Zuckerman Mind Brain Behav Inst New York NY 10027 USA|Columbia Univ Dept Biochem New York NY 10027 USA;

    Columbia Univ Vagelos Coll Phys & Surg Aaron Diamond AIDS Res Ctr New York NY 10027 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号